Retrieve available abstracts of 28 articles: HTML format
Single Articles
June 2025
GEERTS JFM, Vissers PAJ, Mostert B, Wijnhoven BPL, et al Hospital variation in treatment for synchronous metastatic esophageal and gastric
cancer: A nationwide population-based study in the Netherlands.
Int J Cancer. 2025 Jun 5. doi: 10.1002/ijc.35491. PubMedAbstract available
CHAN WC, Millwood I, Kartsonaki C, Du H, et al Adiposity and risks of gastrointestinal cancers: A 10-year prospective study of
0.5 million Chinese adults.
Int J Cancer. 2025;156:2094-2106. PubMedAbstract available
May 2025
PELC Z, Sedlak K, Mlak R, Endo Y, et al Impact of prognostic nutritional index on oncological outcomes and mortality
among advanced gastric cancer patients: European GASTRODATA registry analysis.
Int J Cancer. 2025 May 28. doi: 10.1002/ijc.35489. PubMedAbstract available
March 2025
JIANG XW, Zhang L, Liu ZC, Zhou T, et al Integrative metabolomics and microbiomics analysis reveals distinctive
microbiota-metabolites interactions in gastric carcinogenesis.
Int J Cancer. 2025 Mar 10. doi: 10.1002/ijc.35392. PubMedAbstract available
ENGLISH KA, Goldsworthy M, Willis B, Kooblall KG, et al Calcium sensing receptor expression is downregulated in gastroenteropancreatic
neuroendocrine tumours via epigenetic mechanisms.
Int J Cancer. 2025;156:980-992. PubMedAbstract available
January 2025
SLOTMAN E, Pape M, van Laarhoven HWM, Pouw RE, et al Considerations to forgo systemic treatment in patients with advanced esophageal
or gastric cancer: A real-world evidence study.
Int J Cancer. 2025 Jan 9. doi: 10.1002/ijc.35314. PubMedAbstract available
December 2024
SEWASTJANOW-SILVA M, Kwiatkowski E, Yamashita K, Abdelhakeem A, et al Three biomarkers (HER2, PD-L1, and microsatellite status) in a large cohort of
metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center
experience.
Int J Cancer. 2024;155:2277-2286. PubMedAbstract available
INOUE-CHOI M, Freedman ND, Etemadi A, Hashemian M, et al One-carbon metabolism biomarkers and upper gastrointestinal cancer in the
Golestan Cohort Study.
Int J Cancer. 2024;155:1944-1957. PubMedAbstract available
October 2024
YAN X, Zeng H, Li H, Cao M, et al The current infection with Helicobacter pylori and association with upper
gastrointestinal lesions and risk of upper gastrointestinal cancer: Insights from
multicenter population-based cohort study.
Int J Cancer. 2024;155:1203-1211. PubMedAbstract available
August 2024
LIU J, Gan T, Hu W, Li Y, et al Does ambient particulate matter 1 increase the risk of gastric cancer in the
northwest of China?
Int J Cancer. 2024 Aug 23. doi: 10.1002/ijc.35144. PubMedAbstract available
July 2024
WANG R, Chen XZ Comment on "Infectious pathogens and risk of esophageal, gastric and duodenal
cancers and ulcers in China: A case-cohort study".
Int J Cancer. 2024;155:184-185. PubMed
June 2024
MASETTI M, Al-Batran SE, Goetze TO, Thuss-Patience P, et al Efficacy of ramucirumab combination chemotherapy as second-line treatment in
patients with advanced adenocarcinoma of the stomach or gastroesophageal junction
after exposure to checkpoint inhibitors and chemotherapy as first-line therapy.
Int J Cancer. 2024;154:2142-2150. PubMedAbstract available
NAGEL G, Chen J, Jaensch A, Skodda L, et al Long-term exposure to air pollution and incidence of gastric and the upper
aerodigestive tract cancers in a pooled European cohort: The ELAPSE project.
Int J Cancer. 2024;154:1900-1910. PubMedAbstract available
May 2024
GONZALEZ-PALACIOS S, Compan-Gabucio LM, Torres-Collado L, Oncina-Canovas A, et al The protective effect of dietary folate intake on gastric cancer is modified by
alcohol consumption: A pooled analysis of the StoP Consortium.
Int J Cancer. 2024 May 16. doi: 10.1002/ijc.35004. PubMedAbstract available
December 2023
SASAHARA M, Kanda M, Tanaka C, Shimizu D, et al Therapeutic antibody targeting natriuretic peptide receptor 1 inhibits gastric
cancer growth via BCL-2-mediated intrinsic apoptosis.
Int J Cancer. 2023 Dec 27. doi: 10.1002/ijc.34831. PubMedAbstract available
ZHANG Q, Zhou Y, Song L, Fang W, et al China special issue on gastrointestinal tumors-Improved survival after
multidisciplinary team decision for patients with advanced gastrointestinal
cancer: A multicenter, noninterventional, controlled study.
Int J Cancer. 2023;153:1885-1893. PubMedAbstract available
November 2023
GOETZE TO, Stein A, Lorenzen S, Habibzada T, et al Ramucirumab beyond progression plus TAS-102 in patients with advanced or
metastatic esophagogastric adenocarcinoma, after treatment failure on a
ramucirumab-based therapy.
Int J Cancer. 2023;153:1726-1733. PubMedAbstract available
RIJKEN A, Pape M, Simkens GA, de Hingh IHJT, et al Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence,
treatment and survival.
Int J Cancer. 2023 Nov 2. doi: 10.1002/ijc.34780. PubMedAbstract available
October 2023
FAN XH, Zhang Y, Wang P, Song QQ, et al A noninvasive multianalytical approach establishment for risk assessment and
gastric cancer screening.
Int J Cancer. 2023 Oct 16. doi: 10.1002/ijc.34739. PubMedAbstract available
September 2023
LLACH J, Salces I, Guerra A, Penas B, et al Endoscopic surveillance for familial intestinal gastric cancer in low-incidence
areas: An effective strategy.
Int J Cancer. 2023 Sep 7. doi: 10.1002/ijc.34714. PubMedAbstract available
PALOMAR-CROS A, Straif K, Romaguera D, Aragones N, et al Consumption of aspartame and other artificial sweeteners and risk of cancer in
the Spanish multicase-control study (MCC-Spain).
Int J Cancer. 2023;153:979-993. PubMedAbstract available
August 2023
CHENG L, Chang Y, Xia Z, Liu Y, et al Remote modulation of WWOX by an intronic variant associated with survival of
Chinese gastric cancer patients.
Int J Cancer. 2023 Aug 24. doi: 10.1002/ijc.34703. PubMedAbstract available
CAO F, Sun H, Yang Z, Bai Y, et al Multiple approaches revealed MGc80-3 as a somatic hybrid with HeLa cells rather
than a gastric cancer cell line.
Int J Cancer. 2023 Aug 6. doi: 10.1002/ijc.34677. PubMedAbstract available
July 2023
GOETZE TO, Hofheinz RD, Gaiser T, Schmalenberg H, et al Perioperative FLOT plus ramucirumab for resectable esophagogastric
adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian
GOIM.
Int J Cancer. 2023;153:153-163. PubMedAbstract available
March 2023
GHASEMI-KEBRIA F, Semnani S, Fazel A, Etemadi A, et al Esophageal and gastric cancer incidence trends in Golestan, Iran: an
age-period-cohort analysis 2004-2018.
Int J Cancer. 2023 Mar 21. doi: 10.1002/ijc.34518. PubMedAbstract available
MOHRING C, Manczak A, Timotheou A, Sadeghlar F, et al Perioperative Therapy with Flot4 Significantly Increases Survival in Patients
with Gastroesophageal and Gastric Cancer in A Large Real-World Cohort.
Int J Cancer. 2023 Mar 15. doi: 10.1002/ijc.34511. PubMedAbstract available
KUIJPER SC, Pape M, Vissers PAJ, Jeene PM, et al Trends in best-case, typical and worst-case survival scenarios of patients with
non-metastatic esophagogastric cancer between 2006 and 2020: a population-based
study.
Int J Cancer. 2023 Mar 1. doi: 10.1002/ijc.34488. PubMedAbstract available
February 2023
PAPE M, Kuijper SC, Vissers PAJ, Ruurda JP, et al Conditional relative survival in non-metastatic esophagogastric cancer between
2006 and 2020: a population-based study.
Int J Cancer. 2023 Feb 25. doi: 10.1002/ijc.34480. PubMedAbstract available